Objective: To measure the effect of nasal continuous positive airway pressure (CPAP) on intestinal blood flow velocity responses to enteral feedings and left ventricular output (LVO).
Introduction
Nasal continuous positive airway pressure (CPAP) is used increasingly for the treatment of respiratory distress in premature neonates. Compared with intubation or mechanical ventilation, CPAP is associated with decreased incidence of bronchopulmonary dysplasia and sepsis, and with a trend toward decreased incidence of retinopathy of prematurity and intraventricular hemorrhage. [1] [2] [3] CPAP, however, may contribute to the development of benign gaseous bowel distension in neonates. 4 We previously reported that CPAP administration was associated with an attenuation of the postnatal increase in superior mesenteric artery blood flow velocity (SMA BFV) in preterm infants. 5 Attenuated increases in postnatal SMA BFV are reportedly associated with intestinal dysmotility 6 and with feeding intolerance. 7 Our objective was to further investigate the effect of CPAP on intestinal blood flow velocity by measuring pre-and postprandial SMA BFV in preterm infants when they were receiving CPAP ('on CPAP') and after CPAP was discontinued ('off CPAP').
Methods

This study was approved by the University of South Florida
Institutional Review Board for the Protection of Human Subjects. Informed consent was obtained from the parents of all enrolled infants.
Study design
In this prospective study, SMA BFV responses to enteral feedings were measured in preterm neonates treated with CPAP. On the day infants were weaned from CPAP to room air, pre-and postprandial SMA BFV measurements (0, 30, 60 and 90 min after feeding) were made for one feeding given when infants were on CPAP (FiO 2 0.21), and for one feeding given when infants were off CPAP (room air only). Preprandial measurements were made at least 3 h after the last feeding. Preprandial left ventricular output (LVO) was measured while infants were on and off CPAP. The same type and volume of feeding were used for both studies.
Subjects
Infants admitted to the neonatal intensive care unit at Tampa General Hospital were eligible for enrollment. Inclusion criteria were CPAP administration for respiratory distress or apnea of prematurity, gestational age <34 weeks, birth weight appropriate for gestational age, cardiovascular and hemodynamic stability, and ability to tolerate enteral feedings. Exclusion criteria were clinical evidence of major congenital anomalies or congenital heart disease, or a diagnosis of anemia (venous Hgb<10 g/dl) or polycythemia (venous Hgb>22 g/dl). Infants with umbilical arterial catheters or signs of feeding intolerance, and infants receiving vasoactive medications other than caffeine were also excluded. There were no requirements regarding the volume of enteral feedings administered. Feeding intolerance was defined as gastric residuals or abdominal distension leading to the withholding of one or more enteral feedings.
Enteral feedings
Infants were being fed every 3 h by nasogastric tube by gravity over a period of 5 to 10 min. The same type and volume of feeding were given for SMA BFV studies performed when infants were on and off in CPAP. Feedings were unfortified breast milk or Similac Special Caret formula.
Respiratory care
Infants received standard clinical care for our neonatal intensive care unit, which includes CPAP administration for respiratory distress or apnea. CPAP was administered through a two-pronged nasal cannula with Inca nasal prongs (Ackrad Laboratories, Cranford, NJ, USA) using a Dräger Babylog 8000 ventilator. As the infant's condition improved, oxygen was decreased to FiO 2 0.21 while the infants continued to receive CPAP pressures of 5 or 4 cm H 2 O. At the discretion of the attending neonatologist, CPAP FiO 2 0.21 was discontinued, and the infant was observed on room air only for any signs of respiratory distress and to maintain goal O 2 saturations between 88 and 92%. Infants were removed from the study if they did not tolerate weaning from CPAP or if they did not tolerate enteral feedings at the time of the SMA BFV measurements.
Doppler ultrasound studies SMA BFV was measured using pulsed Doppler ultrasound (Acuson Sequoia C512, Mountain View, CA, USA) and a 10.0-MHz transducer. The sampling volume of the pulsed Doppler was placed 3 mm distal to the origin of the SMA using a real-time two-dimensional image from a longitudinal abdominal approach. When five stable consecutive waveforms were obtained, the curve was traced and the mean velocity (MV; Figure 1 ), peak systolic velocity (PSV; Figure 2 ) and end diastolic velocity (EDV; Figure 3) were recorded. The resistance index was calculated as PSVÀEDV/ PSV. The LVO was measured according to the method of Walther et al. 8 In the sagittal scan via the suprasternal notch, the Doppler sampling volume was placed in the ascending aorta and the temporal mean blood flow velocity was measured. The aortic root dimension was measured on the M-mode echocardiogram in early diastole. Left ventricular output was calculated as follows:
/kg body weight, where Q is LVO in ml/min, d the diameter of the aorta in cm and V the temporal mean blood flow velocity in cm/s. Evidence of a patent ductus arteriosus was noted at the time the LVO was measured.
All SMA BFV measurements were made by a single operator (CM). Intra-class correlation coefficients for PSV, MV and EDV were <0.01.
Statistical analyses
A two-way paired-samples t-test was used to analyze differences in preprandial SMA BFV and physiologic measurements when infants were on CPAP versus off CPAP. Wilcoxon signed ranks test for two related samples was used to compare differences in the increase from baseline to peak SMA BFV when infants were on CPAP versus off CPAP. SPSS (SPSS Inc., Version 14.0, Chicago IL, USA) was 
Results
Twenty infants were enrolled; all infants received CPAP due to respiratory distress. One infant did not tolerate weaning from CPAP and one infant did not tolerate enteral feedings. The mean birth weight and gestational age of the 18 infants who completed the study were 1793±350 g and 32.1±1.1 weeks, respectively ( Table 1) . None of the 18 infants developed necrotizing enterocolitis or significant feeding intolerance during hospitalization. Infants were 2.5±0.8 days old when the first SMA BFV measurements (on CPAP) were made. The mean feeding volume given for measurements when on CPAP and off CPAP was 6.1±2.6 ml. Clinical variables that may affect SMA BFV are listed in Table 1 . For each subject, the values for these variables were the same when SMA BFV studies were conducted when on and off CPAP. There were no significant differences in SMA BFV between infants who did or did not have a patent ductus arteriosus.
Preprandial MV and PSV were significantly lower when infants were on CPAP. Preprandial EDV and other physiologic variables, including LVO, were similar when infants were on CPAP versus off CPAP, with the exception of respiratory rate, which was moderately increased when infants were off CPAP ( Table 2 ). The increase in SMA BFV from 0 to 30 min was significantly greater when infants were on CPAP versus off CPAP (Table 3) .
The mean 0, 30, 60 and 90 min resistance indices when infants were on CPAP were 0.81±0.08, 0.80±0.06, 0.80±0.07 and 0.80±0.08, and when infants were off CPAP they were 0.82±0.06, 0.81±0.06, 0.81±0.07 and 0.82±0.06, respectively. There were no significant differences in resistance indices when infants were on CPAP versus off CPAP.
Discussion
The lower preprandial SMA BFV when infants were on CPAP is in agreement with our previous finding that CPAP administration is a factor that contributes to attenuated postnatal increases in preprandial SMA BFV in preterm infants. 5 An additional finding of the present study is that the increase in SMA BFV from 0 to 30 min after feeding was greater when infants were on CPAP versus off CPAP. To our knowledge, these are the only reports of CPAP effects on intestinal blood flow velocity.
After birth, intestinal blood flow increases to support the dramatic increase in intestinal growth and oxygen uptake that occurs during the first few postnatal weeks. 5, [9] [10] [11] [12] [13] [14] [15] Other extrinsic factors that affect intestinal blood flow velocity in preterm infants include the type and volume of enteral feeding given, 10,13 -17 various pharmacologic agents 18,19 -21 and phototherapy. 22, 23 Greater increases in postnatal and postprandial SMA BFV in preterm neonates are associated with less intestinal dysmotility 6 and with better tolerance to enteral feedings. 7 The greater increase in SMA BFV from 0 to 30 min after feeding while on CPAP may relate to CPAP effects on gastric emptying time. The response of vessels to food stimulus (gastric emptying and chyme progression) is of key importance in the control of gut blood flow following feeding. [24] [25] [26] Gounaris et al. 27 reported that gastric emptying time was significantly shorter in preterm neonates Table 1 Demographic characteristics and clinical variables of 18 infants enrolled in the SMA BFV study
Demographic characteristics
Birth weight (g) 1793±350 Gestational age (weeks) 32.1±1.1
Variables at the time studies were performed Age (days) 2.5±0.8 Volume of study feedings (ml/kg) 6.1±3.6
Nutrition, no. Abbreviations: For abbreviation see Table 2 ; CI, confidence interval. Data are the median (95% CI).
Nasal CPAP affects intestinal blood flow in preterm infants T Havranek et al treated with CPAP. The authors speculated that the shorter emptying time was due to CPAP pressure exerted on the stomach by the diaphragm. The clinical implications of earlier maximum postprandial SMA BFV or shorter gastric emptying times in this population are unknown. However, delayed gastric emptying in preterm infants is associated with feeding intolerance. 28 It is unclear if our findings relate to the benign gaseous bowel distension known as CPAP belly syndrome. 4 The condition, which may occur in over 50% of preterm infants on CPAP, is characterized by a soft, distended abdomen. Radiographic findings may include uniform dilatation of the small and large bowel loops without evidence of thickening of the bowel wall, pneumatosis or free air. The syndrome usually occurs after 4 to 7 days of CPAP treatment, and is most common in infants born with extremely low birth weights. 3, 4, 27 In the present study, CPAP at pressures of 4 or 5 cm H 2 O did not affect cardiac output. This finding is in agreement with that of Hsu et al., 29 who found no effect of CPAP on cardiac output in neonates until the pressures reached 8 or 10 cm H 2 O. In adults, CPAP reportedly has no effect on cardiac output up to 15 cm H 2 O, 29, 30 and it decreases cardiac output at 20 cm H 2 O. 31 These data indicate that the effects of CPAP on cardiac output are dependent on the amount of pressure delivered, and may explain our finding that CPAP delivered at relatively low pressure did not affect cardiac output.
A limitation of most studies of nasal CPAP is the difficulty in controlling factors that can affect delivered CPAP pressure, including mouth closure, inappropriate prong size or placement, and airway obstruction from secretions. While we attempted to control these factors, the insertion of a neonatal esophageal balloon catheter to estimate intrapleural pressure may help to ensure that the intended CPAP pressure is delivered. 32 Our study included relatively stable infants with gestational ages X30 weeks. Additional studies that include a larger number of infants with younger gestational ages are needed to determine if CPAP effects on SMA BFV relate to conditions such as CPAP belly syndrome, feeding intolerance and necrotizing enterocolitis.
